Replies to post #431509 on Elite Pharmaceuticals Inc (ELTP)

[jour_trader]

Relationship with Elite didn't last very long. 

[the dude 2]

imo, Teva has the most positive impact on business if they acquire ELTP, significantly over Pfizer, Eli Lily, Merck, Sandoz, Viatris, Lupin, Hikma, Novartis, and Perrigo. Those are my top 10, and Teva seems to be the most affected by 200% tariffs. Their 'newer' business model aligns perfectly with domestic acquisition, but I'm still working on the data; I could be missing something. Who do you think is most affected by 200% tariffs, and who would be a better candidate if tariffs are reduced to normal rates or slightly higher than normal rates?